tirzepatide anesthesia guidelines NPO Guidelines/Practice Patterns Elective peri‐operative management of adults

Interfaces 87 TraxlerM

[00:25:10] Emily Field: Two to four strength training sessions per week built around these movements can make a meaningful difference

Uniquely, these two agents from the same company may work as a complementary pair: the ATTAIN-MAINTAIN trial demonstrated that patients can achieve maximum weight loss with injectable tirzepatide and then switch to oral orforglipron for maintenance

As new treatments are developed for fibromyalgia, researchers might first put them to the TSPO test or something similar

KFF Medicaid Coverage of and Spending on GLP-1s, January 2026 The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible Medicare beneficiaries Wegovy weight-loss access at $50/month outside Part D not counting toward the $2,100 OOP cap